Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies

Journal of International Medical Research

Volumn 37, Issue 4, 2009, Pages 1065-1074

  Ma, Zhenghai ^a   Liu, Lihong ^a   Zhang, Fuchun ^a   Yu, Meng ^a   Wang, Kai ^a   Luo, Jianmin ^a   Liu, Kaijiang ^b   Chen, Bangdang ^a   Xu, Lu ^a  

^a XINJIANG UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Bacterium; Cervical cancer; HPV 16; Infection; Replication

Indexed keywords

RNA 16S; BACTERIAL PROTEIN; BACTERIAL RNA; CAPSID PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; VIRUS RNA;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE ASSOCIATION; DNA ISOLATION; DNA SEQUENCE; ENTEROCOCCUS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; MICROORGANISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS; TUMOR BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS PARTICLE; WESTERN BLOTTING; ADENOCARCINOMA; BACTERIUM; BIOPSY; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMID; ULTRASTRUCTURE; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS GENE;

ADENOCARCINOMA; BACTERIA; BACTERIAL PROTEINS; BIOPSY; CAPSID PROTEINS; FEMALE; GENES, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; REPRESSOR PROTEINS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS;

EID: 70350511410     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700411     Document Type: Article

References (31)

1. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19. (Pubitemid 29406813)
2. Ho GY, Bierman R, Beardsley L, et al: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428. (Pubitemid 28135669)
3. Sellors JW, Karwalajtys TL, Kaczorowski J, et al: Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003; 168: 421-425. (Pubitemid 36255727)
4. Castle PE, Hillier SL, Rabe LK, et al: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10: 1021-1027.
5. Jones CJ, Brinton LA, Hamman RF, et al: Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990; 50: 3657-3662. (Pubitemid 20194112)
6. Ma ZH, Zhang FC, Mei XD, et al: Mutations of human papillomavirus (HPV) 16 type L1 genes from cervical carcinoma biopsies in southern Xinjiang Uygur women. Zhonghua Yi Xue Za Zhi 2004; 84: 987-991 [in Chinese].
7. Ma CL, Li YJ, Zhang FC, et al: Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction. Zhonghua Yi Xue Za Zhi 2004; 84: 469-473 [in Chinese].
8. Xu L, Liu LH, Li YJ, et al: Study on the expression level of XinJiang strain HPV-16 L1 in eukaryotic cells. Chin J Cell Biol 2008; 30: 499-503 [in Chinese].
9. Engvall EO, Pettersson B, Persson M, et al: A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol 1996; 34: 2170-2174. (Pubitemid 26272198)
10. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.
11. Zhao KN, Frazer IH: Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions. J Virol 2002; 76: 3359-3364.
12. Seedorf K, Krammer G, Durst M, et al: Human papillomavrius type 16 DNA sequence. Virology 1985; 145: 181-185. (Pubitemid 15234421)
13. Hudelist G, Manavi M, Pischinger KI, et al: Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004; 92: 873-880. (Pubitemid 38251391)
14. Clifford GM, Smith JS, Aguado T, et al: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-105. (Pubitemid 36897943)
15. Bosch FX, Manos MM, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
16. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350. (Pubitemid 37328947)
17. Angeletti PC, Kim K, Fernandes FJ, et al: Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J Virol 2002; 76: 3350-3358. (Pubitemid 34224537)
18. Zhao KN, Frazer IH: Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol 2002; 76: 12265-12273. (Pubitemid 35304324)
19. Kalantari M, Blennow E, Hagmar B, et al: Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 2001; 10: 46-54. (Pubitemid 32180183)
20. Durst M, Croce CM, Gissmann L, et al: Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987; 84: 1070-1074. (Pubitemid 17031570)
21. Arias-Pulido H, Peyton CL, Joste NE, et al: Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006; 44: 1755-1762. (Pubitemid 43726265)
22. Brinton LA, Hamman RF, Huggins GR, et al: Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987; 79: 23-30. (Pubitemid 17102546)
23. Delves PJ, Roitt IM: The immune system. First of two parts. N Engl J Med 2000; 343: 37-49. (Pubitemid 30447991)
24. Reid G: Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001; 73 (2 suppl): 437S-443S.
25. Reid G, Seidenfeld A: Drug resistance amongst uropathogens isolated from women in a suburban population: laboratory findings over 7 years. Can J Urol 1997; 4: 432-437.
26. Corbishley CM: Microbial flora of the vagina and cervix. J Clin Pathol 1977; 30: 745-748.
27. Von Gruenigen VE, Coleman RL, Li AJ, et al: Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patients. Obstet Gynecol 2000; 96: 23-27.
28. Brook I, Barrett CT, Brinkman CR, et al: Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. Pediatrics 1979; 63: 451-455. (Pubitemid 9120946)
29. Winer RL, Lee SK, Hughes JP, et al: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-226.
30. Rintala MA, Grenman SE, Puranen MH, et al: Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol 2005; 43: 376-381.
31. Burchell AN, Richardson H, Mahmud SM, et al: Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163: 534-543.